Renal impairment at presentation is not an adverse prognostic factor in multiple myeloma patients treated with new agents
Fifteen to forty per cent of multiple myeloma patients have renal impairment at diagnosis. The Durie-Salmon staging included renal impairment as an adverse prognostic factor and so does the International Staging System, since β2-microglobulin correlates with both tumour burden and renal impairment....
| Main Author: | |
|---|---|
| Other Authors: | , , , , , |
| Format: | article |
| Language: | eng |
| Published: |
2014
|
| Subjects: | |
| Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000400007 |
| Country: | Portugal |
| Oai: | oai:scielo:S0872-01692014000400007 |